NUT has been found to fuse with bromodomain-containing proteins 3 and 4 (BRD3 and BRD4) in NUT midline carcinoma (NMC), a very rare, extremely aggressive, and genetically defined human cancer. NMC has recently been designated as a sub classification of poorly differentiated squamous cell carcinoma. In the majority of NMCs (~75%), most of the coding sequence is fused to form chimeric genes that encode BRD-NUT fusion proteins.